Incyte (INCY) Net Margin (2010 - 2026)
Incyte's (INCY) quarterly Net Margin came in at 34.98% in Q2 2026, up 166.0% YoY from 13.15% in Q2 2025, and up 46.77% on a QoQ basis from 23.83% in Q1 2026.
Powered by 
Analysis
Incyte (INCY) Net Margin (2010 - 2026) Analysis & Trends
Incyte (INCY) has 17 years of Net Margin data on file, last reported at 34.98% in Q2 2026.
- Quarterly Net Margin rose 166.0% year-over-year to 34.98% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 27.71% (up 871.0% YoY) and the FY2025 annual result came in at 25.03%, up 2426.0% from the prior year.
- Net Margin grew to 34.98% in Q2 2026, from 23.83% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 34.98% in Q2 2026 to a low of 42.6% in Q2 2024.
- A 5-year average of 14.63% and a median of 18.17% in 2023 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2024 — Net Margin plunged 6392 bps — and 2025, when it soared 7591 bps.
- Tracing INCY's Net Margin over 5 years: stood at 3.07% in 2022, then surged by 546 bps to 19.84% in 2023, then fell by 14 bps to 17.07% in 2024, then rose by 16 bps to 19.86% in 2025, then surged by 76 bps to 34.98% in 2026.
- The last three Net Margin figures came in at 34.98% (Q2 2026), 23.83% (Q1 2026), and 19.86% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 31.16% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -539.31% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 13.90% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 12.74% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 12.09% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -3.12% |
| 10 | Incyte | 25.44 Bn | 20.91 Bn | 1.57 Bn | 34.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34.98% |
| Mar 31, 2026 | 23.83% |
| Dec 31, 2025 | 19.86% |
| Sep 30, 2025 | 31.05% |
| Jun 30, 2025 | 33.32% |
| Mar 31, 2025 | 15.03% |
| Dec 31, 2024 | 17.07% |
| Sep 30, 2024 | 9.36% |
| Jun 30, 2024 | -42.60% |
| Mar 31, 2024 | 19.25% |
| Dec 31, 2023 | 19.84% |
| Sep 30, 2023 | 18.64% |
| Jun 30, 2023 | 21.32% |
| Mar 31, 2023 | 2.68% |
| Dec 31, 2022 | 3.07% |
| Sep 30, 2022 | 13.70% |
| Jun 30, 2022 | 17.71% |
| Mar 31, 2022 | 5.18% |
| Dec 31, 2021 | 65.35% |
| Sep 30, 2021 | 22.35% |